ARCHIVES

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

Velcade Addition Can Improve Graft-Versus-Host Outcomes

December 27, 2013

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

In Brief: Construction Grant Application Deadline for 75-25% Funding Oct. 1; Fordham Quits

April 29, 1977

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005

Cancer Center Directors Contemplate the Role of Centers In the 21st Century

May 7, 1999